Enzymatic Precision: Advancing Complex Small Molecule Synthesis using Biocatalysis
Synthetic chemistry is the default approach for
pharmaceutical small molecule manufacturing, able to prepare diverse molecular
entities, not found in nature, using well proven methodologies. However, in
recent years, small molecule therapeutics have become increasingly complex in
design to provide greater potency, efficacy and specificity. This industry
trend poses additional challenges for synthetic chemistry to deliver effective
manufacturing routes that are atom-efficient, scalable, low-cost and
sustainable, particularly where stereo- and/or regio-selective syntheses are
necessary. This webinar highlights the opportunity for the exquisite
selectivity of enzymatic biotransformations, conducted in vitro or in
vivo, to overcome these challenges of tomorrow’s small molecule
pharmaceutical manufacturing.
Ingenza ltd
-
Country/Region:United Kingdom
-
On CPHI since:2025
-
Employees:50 - 99